1. 2020
  2. Identification of novel trace amine-associated receptor-1 ligands among newly synthesized and clinically used drugs

    Kanov, E., Gerasimov, A., Koren'kova, O. & Gainetdinov, R., Nov 2020, In: European Neuropsychopharmacology. 40, Supplement 1, p. S272-S273 P.480.

    Research output: Contribution to journalMeeting Abstractpeer-review

  3. Novel 1-amidino-4-phenylpiperazines as potent agonists at human taar1 receptor: Rational design, synthesis, biological evaluation and molecular docking studies

    Francesconi, V., Cichero, E., Kanov, E. V., Laurini, E., Pricl, S., Gainetdinov, R. R. & Tonelli, M., Nov 2020, In: Pharmaceuticals. 13, 11, p. 1-26 26 p., 391.

    Research output: Contribution to journalArticlepeer-review

  4. 2010
  5. Increased subventricular zone-derived cortical neurogenesis after ischemic lesion

    Kreuzberg, M., Kanov, E., Timofeev, O., Schwaninger, M., Monyer, H. & Khodosevich, K., Nov 2010, In: Experimental Neurology. 226, 1, p. 90-99 10 p.

    Research output: Contribution to journalArticlepeer-review

  6. 2002
  7. Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia.

    Kanov, E. V., Novozheeva, T. P. & Saratikov, A. S., 2002, In: Eksperimental'naia i klinicheskaia farmakologiia. 65, 2, p. 56-58 3 p.

    Research output: Contribution to journalArticlepeer-review

  8. 2001
  9. Halodif pharmacokinetics in brain, heart, and liver

    Kanov, E. V., Novozheeva, T. P. & Saratikov, A. S., 2001, In: Pharmaceutical Chemistry Journal. 35, 9, p. 477-479 3 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 Next

ID: 42785665